Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
San Antonio, TX
The final day of SABCS 20 included the session “View from the Trenches: What Will You Do on Monday Morning,” featuring a multidisciplinary panel of experts who discussed some of the most important data and study findings presented during the meeting.
In this year’s William L. McGuire Memorial Lecture, Mary-Claire King, PhD, called for universal testing of women for BRCA1 and BRCA 2 mutations to prevent breast and ovarian cancer.
Large prospective cohort studies have provided valuable insights into breast cancer risk at the population level. But broad characteristics such as age, body mass index, type of cancer, age at diagnosis, and progression are just the beginning.
Tumor infiltrating lymphocytes are an immunologic novelty that is moving toward clinical utility in breast cancer prognosis and treatment selection. In her AACR Award Lecture, Sherene Loi, PhD, FRACP, described ongoing research into the role of TILs in breast cancer prognosis and progression.
Use the SABCS mobile app to complete session surveys and evaluations for the sessions you attended. Please be sure to go through the entire survey to ensure you receive the proper credit.
With the SABCS 20 Virtual Symposium in the books, the SABCS Executive and Program Planning committees would like to thank everyone who participated in planning and presenting this year’s meeting, and a special thanks to everyone across the globe who attended.